Validation of an 18F-labeled biphenylalkyne as a positron emission tomography imaging agent for β-amyloid plaques☆
To access this article, please choose from the options below
☆ This work was supported by a grant (no. 34004) from Chang Gung Medical Research Program.
PII: S0969-8051(09)00034-1
doi:10.1016/j.nucmedbio.2009.01.013
© 2009 Elsevier Inc. All rights reserved.
